ADIPOR2, encoding adiponectin receptor2, has been implicated in cardiovascular diseases [40, 41], fatty liver disease [42], diabetes [43], diabetic nephropathy [44], and bone metabolic disorders [45]. Here, ADIPOR2 is linked to metabolic bone disorder.